Thank you for taking part in the GSK-CRS LAII Conference!*

 

Keynote Speaker

Robert Langer, Ph.D., David H. Koch Institute Professor, Massachusetts Institute of Technology

 

Robert Langer

 

Conference Agenda

TUESDAY, APRIL 18

8:15 – 8:30 a.m. Conference Opening Remarks
8:30 – 8:45 a.m.
 Welcome Address
John Lepore, M.D., Sr. Vice President, R&D Pipeline, GSK


8:45 – 9:00 a.m.
Break

9:00 – 10:30 a.m.
Development of Long-Acting Injectable and Implantable Products: FDA and Industry Perspectives

Session Chairs:
Kamlesh Patel, Ph.D., Head, Sterile Drug Product design Development, GSK
Christopher A. Rhodes, Ph.D., President and CEO, Drug Delivery Experts

Speakers:
Thomas Tice, Ph.D., Sr. Director, Evonik Corporation
Yan Wang, Ph.D., Office of Standards and Research, Office of Generic Drugs, FDA
Julius Remenar, Ph.D., Research Fellow, Alkermes

10:30 – 11:00 a.m. Refreshment Break

11:00 a.m. – 12:30 p.m.
Novel Controlled-Release Approaches for Peptide and Protein Delivery

Session Chairs:
Doug Nesta, Ph.D., Director of Biopharm Development, GSK
Thomas Tice, Ph.D., Sr. Director, Evonik Corporation


Speakers:
Christopher A. Rhodes, Ph.D., President and CEO, Drug Delivery Experts
Daniel Santi, MD, Ph.D., President, Prolynx LLC
Lasse Leino, Ph.D., CEO, DelSiTech

12:30 – 1:30 p.m. Lunch and Networking

1:30 – 3:00 p.m.
Understanding and Taking Advantage of Biological Dynamics to Design Long-Acting Products

Session Chairs:
Manish Gupta, Ph.D., Head of Biopharmaceutics, Drug Product Design and Development, GSK
Andrew Owen, Ph.D., Professor, Dept. of Molecular and Clinical Pharmacology, University of Liverpool

Speakers:
Randy Mrsny, Ph.D., Professor, Dept. of Pharmacy and Pharmacology, University of Bath
Marco Siccardi, Ph.D., Lecturer, Molecular and Clinical Pharmacology, University of Liverpool
Howard Gendelman, M.D., Margaret R. Larson Professor of Internal Medicine and Infectious Disease, University of Nebraska Medical Center

3:00 – 3:30 p.m. Refreshment Break

3:30 – 5:00 p.m. 
Long-Acting Injectables and Implantables for the Developing World

Session Chairs:
Sherene Min, MD, MPH, Medicine Development Leader, ViiV Healthcare
Marc Baum, Ph.D., President, Oak Crest Institute

Speakers:
Andrew Owen, Ph.D., Professor, Dept. of Molecular and Clinical Pharmacology, University of Liverpool
Gregory Kopf, Ph.D., Director of Research and Development, Contraceptive Technology and Innovation, FHI 360
William Spreen, Pharm.D., Vice President, Medicine Development Leader, ViiV Healthcare

5:00 – 6:00 p.m.  Poster Viewing and Refreshments
6:30 – 9:30 p.m.
Reception at the Barnes Foundation


WEDNESDAY, APRIL 19

8:30 – 10:00 a.m.
New Developments in Implant Devices for Reversible Long-Acting Therapy

Session Chairs:
William Spreen, Pharm.D., Vice President, Medicine Development Leader, ViiV Healthcare
Greg Kopf, Ph.D., Director of Research and Development, Contraceptive Technology and Innovation, FHI 360

Speakers:
Alex Schwarz, Ph.D., Vice President, Early Development, Braeburn Pharmaceuticals
Marc Baum, Ph.D., President, Oak Crest Institute
Cheryl Blanchard, Ph.D., President and CEO, Microchips Biotech

10:00 – 10:30 a.m. Refreshment Break

10:30am – 12:30 p.m.
Emerging Controlled-Release Parenteral Strategies

Session Chairs:
Matthew Burke, Ph.D., Head of Drug Delivery, GSK
Randy Mrsny, Ph.D., Professor, Dept. of Pharmacy and Pharmacology, University of Bath

Speakers:
Robert Prud'homme, Ph.D., Professor of Chemical and Biological Engineering, Princeton University
Omid Veiseh, Ph.D., Assistant Professor of Bioengineering, CPRIT Scholar in Cancer Research, Rice University
Steven Schwendeman, Ph.D., Chair and Ara G. Paul Professor of Pharmaceutical Sciences, College of Pharmacy, and Professor of Biomedical Engineering, College of Engineering, University of Michigan
David Mooney, Ph.D., Robert P. Pinkas Family Professor of Bioengineering, Wyss Institute, Harvard

12:30 – 2:00 p.m. Lunch, Networking, and Poster Viewing

2:00 – 3:00 p.m. Closing Keynote Address
Robert Langer, Ph.D., Massachusetts Institute of Technology

3:00 – 3:30 p.m. Conference Closing Remarks

  

Conference Information

 

CONFERENCE LOCATION

GSK Navy Yard
5 Crescent Drive
Philadelphia, PA 19112

GSK-CRS Long-Acting Injectables and Implantables Conference attendee names have been entered into the GSK Navy Yard security system. Upon arrival at the GSK Navy Yard facilities, you will provide your name to the security guard at the desk in the Atrium Lobby. The security guard will confirm your participation at the conference and direct you to the Registration Desk across from the security desk. Here, staff will provide you with a name badge that provides you access to the GSK Navy Yard facility. You will walk through the security gates and proceed straight down the Atrium to the elevator bank located in the back of the building on the left-hand side. Take this elevator to the 4th floor where staff will direct you to the Multipurpose Room, where the conference will be held. If you have any questions on site, please ask any of our
GSK-CRS staff members and we will assist you.

 

TUESDAY NIGHT RECEPTION LOCATION

Barnes Foundation
2025 Benjamin Franklin Parkway
Annenberg Court
Philadelphia, PA 19103

Motor coaches will be providing transportation to and from the reception. After the poster viewing session ends on Tuesday, April 18, we will have buses transporting attendees from the GSK Navy Yard to the Barnes Foundation beginning at 6:15 p.m. As the reception comes to a close, these buses will provide transportation back to attendee hotels beginning at 8:45 p.m. through to 9:30 p.m.

 

HOTEL LOCATIONS

Courtyard Philadelphia South at the Navy Yard
1001 Intrepid Ave
Philadelphia, PA, 19112
U.S.A. 

Marriott Philadelphia Airport Location
Philadelphia International Airport - Terminal B
1 Arrivals Road
Philadelphia, PA 19153

 

QUESTIONS OR CONCERNS?

Please contact Brianna Plank with any questions or concerns regarding this conference.

 

*Download a copy of the GSK-CRS Long-Acting Injectables and Implantables Program Book 

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link